VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $35,750,000 | +22.4% | 1,536,875 | -16.3% | 0.03% | +37.5% |
Q1 2018 | $29,204,000 | -38.7% | 1,835,907 | -19.4% | 0.02% | -36.8% |
Q4 2017 | $47,650,000 | +75.5% | 2,278,615 | +20.0% | 0.04% | +72.7% |
Q3 2017 | $27,145,000 | +14.8% | 1,898,117 | +39.3% | 0.02% | +4.8% |
Q2 2017 | $23,643,000 | -6.9% | 1,362,232 | -40.9% | 0.02% | -8.7% |
Q1 2017 | $25,390,000 | +63.8% | 2,305,404 | +115.9% | 0.02% | +64.3% |
Q4 2016 | $15,504,000 | -48.1% | 1,067,768 | -12.4% | 0.01% | -48.1% |
Q3 2016 | $29,846,000 | +27.5% | 1,218,570 | +4.4% | 0.03% | +12.5% |
Q2 2016 | $23,410,000 | -6.2% | 1,166,691 | +23.0% | 0.02% | -14.3% |
Q1 2016 | $24,970,000 | -59.8% | 948,269 | +54.7% | 0.03% | -54.8% |
Q4 2015 | $62,079,000 | +2.9% | 613,089 | +80.6% | 0.06% | +10.7% |
Q3 2015 | $60,318,000 | +40.0% | 339,515 | +74.9% | 0.06% | +47.4% |
Q2 2015 | $43,092,000 | +9.9% | 194,135 | -2.2% | 0.04% | +2.7% |
Q1 2015 | $39,206,000 | +158.2% | 198,452 | +87.5% | 0.04% | +184.6% |
Q4 2014 | $15,187,000 | +111.6% | 105,861 | +93.7% | 0.01% | +116.7% |
Q3 2014 | $7,178,000 | -3.9% | 54,656 | -7.3% | 0.01% | -14.3% |
Q2 2014 | $7,467,000 | -46.9% | 58,938 | -44.7% | 0.01% | -53.3% |
Q1 2014 | $14,055,000 | -9.0% | 106,662 | -19.1% | 0.02% | +7.1% |
Q4 2013 | $15,450,000 | +7.1% | 131,886 | -4.5% | 0.01% | 0.0% |
Q3 2013 | $14,426,000 | +49.1% | 138,053 | +22.6% | 0.01% | +40.0% |
Q2 2013 | $9,676,000 | – | 112,569 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |